XLV is a health care sector ETF from SPDR. Its largest disclosed positions include LLY, JNJ, and ABBV, and the top three holdings account for 32.09% of portfolio weight shown here. On ETF Overlap Checker, it currently connects to 64 comparison pages.
Issuer
SPDR
Asset Class
Equity
Holdings
60
Compare Pages
64
The State Street Health Care Select Sector SPDR ETF (XLV) is designed to reflect, before expenses, the price and yield performance of the Health Care Select Sector Index. This benchmark offers a clear representation of the healthcare industry within the S&P 500. The fund provides focused exposure to companies across diverse healthcare fields, such as pharmaceuticals, medical equipment and supplies, healthcare providers and services, biotechnology, life sciences tools and services, and health technology. It allows investors to make targeted strategic or tactical allocations that are more precise than those offered by traditional style-based investment vehicles.
Review the methodology for the overlap formula and visit the ETF directory for the full set of indexed fund hubs.
Compare XLV with another ETF
The disclosed top holdings suggest a more concentrated portfolio than a plain broad-market fund. LLY, JNJ, and ABBV account for much of the visible weight, with the top three at 32.09% and the top ten at 59.1%. Sector labels are limited in the visible top holdings, so the concentration read is driven mainly by the largest names themselves.
XLV is focused enough that overlap should spike when the comparison fund targets the same sector or theme, and fall much faster against diversified market ETFs. The most visible positions, including LLY, JNJ, and ABBV, are often the names that drive those higher-overlap matchups.
On this site, investors often compare XLV with VOO, VTI, and QQQ. Those matchups usually answer a simple question: does adding this fund create a different sleeve, or does it mostly duplicate exposure you already own? XLV currently connects to 64 live comparison pages.
Concentration
These numbers help show whether XLV behaves more like a broad portfolio building block or a fund where the biggest positions dominate the ride.
Visible Sector Mix
Sector labels are limited in the visible top holdings for XLV, so the strongest signal here is still the size of the largest positions themselves.
These holdings help explain how XLV overlaps with other funds. The top ten disclosed positions represent 59.1% of the portfolio shown here.
| Holding | Name | Sector | Weight |
|---|---|---|---|
| LLY | Eli Lilly & Co | N/A | 13.74% |
| JNJ | Johnson & Johnson | N/A | 11.10% |
| ABBV | AbbVie Inc | N/A | 7.25% |
| MRK | Merck & Co Inc | N/A | 5.63% |
| UNH | UnitedHealth Group Inc | N/A | 4.62% |
| AMGN | Amgen Inc | N/A | 3.57% |
| TMO | Thermo Fisher Scientific Inc | N/A | 3.48% |
| ABT | Abbott Laboratories | N/A | 3.37% |
| GILD | Gilead Sciences Inc | N/A | 3.26% |
| ISRG | Intuitive Surgical Inc | N/A | 3.09% |
Use these pages to see whether adding XLV changes your exposure or mostly duplicates positions you already own.